Molecular Biometrics is developing diagnostic procedures to identify embrio viability tests for in vitro fertilization.
More
Molecular Biometrics Inc.
Facts from the Community
From the BioVenturist base
Technology Focus:
Medical focus:
Investment Round:
| Investment round | Amount raised | Date | Investors |
|---|---|---|---|
|
|
We can tell you that Molecular Biometrics Inc. is a…
If you know more about Molecular Biometrics Inc., you can add more facts here »
Similar topics in Freebase
-
Regulus Therapeutics
-
Millennium Pharmaceuticals
Millennium Pharmaceuticals, Inc., The Takeda Oncology Company is a leading biopharmaceutical company based in Cambridge, Massachusetts. The Company markets Velcade (bortezomib) for injection, a cancer product, and has a growing clinical development pipeline of product candidates. Millennium... -
Genta
Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company’s research platforms are anchored by two major programs that center on oligonucleotides (RNA- and DNA-... -
EntreMed, Inc.
-
Cogentus Pharmaceuticals Inc.
Cogentus is a developer of antiplatelet therapies for cardiovascular disease. -
Meldex International Plc
-
Synthon BV
-
Alexion Pharmaceuticals
-
Algeta ASA
-
Celgene
Celgene Corporation (NASDAQ: CELG) is an American biotechnology company that manufacturers of drug therapies for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major products are Thalomid (thalidomide), which is approved for...
You can help improve this topic by adding more facts here
